Page last updated: 2024-08-26

arctiin and Disease Exacerbation

arctiin has been researched along with Disease Exacerbation in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hasumura, M; Hirose, M; Imai, T; Onose, J; Ueda, M	1
Azeloglu, EU; Chen, Y; Das, B; Deng, Y; He, JC; Lee, K; Li, X; Liu, R; Ma, Y; Muwonge, AN; Wang, T; Wei, C; Wong, NJ; Yang, S; Zhang, W; Zhong, Y	1

Other Studies

2 other study(ies) available for arctiin and Disease Exacerbation

Article	Year
Lack of a significant effect of arctiin on development of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats. Nutrition and cancer, 2007, Volume: 57, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation, Neoplastic; Disease Progression; Dose-Response Relationship, Drug; Female; Furans; Glucosides; Incidence; Mammary Neoplasms, Experimental; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley	2007
Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes. Nature communications, 2019, 10-04, Volume: 10, Issue:1 Topics: Animals; Arctium; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Furans; Humans; Lignans; Male; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Nitric Oxide Synthase Type III; Podocytes; Protein Phosphatase 2; Streptozocin; Treatment Outcome	2019

Article

Year

Lack of a significant effect of arctiin on development of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats.

Nutrition and cancer, 2007, Volume: 57, Issue:2

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation, Neoplastic; Disease Progression; Dose-Response Relationship, Drug; Female; Furans; Glucosides; Incidence; Mammary Neoplasms, Experimental; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley

2007

Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes.

Nature communications, 2019, 10-04, Volume: 10, Issue:1

Topics: Animals; Arctium; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Furans; Humans; Lignans; Male; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Nitric Oxide Synthase Type III; Podocytes; Protein Phosphatase 2; Streptozocin; Treatment Outcome

2019